AbbVie Presents Late-Breaking Data on Risankizumab in Psoriatic Arthritis at the 30th European Academy of Dermatology and Venereology Congress Biotech Investing
Bristol Myers Squibb Data at the EADV 30th Anniversary Congress Highlight the Growing Body of Evidence on Deucravacitinib and Scientific Advancements for Patients with Serious Dermatologic Diseases Biotech Investing
AbbVie Presents New Analyses Evaluating RINVOQ® in Atopic Dermatitis Across Patient Characteristics and Body Regions at EADV Virtual Congress Biotech Investing
FDA Approves QULIPTA , the First and Only Oral CGRP Receptor Antagonist Specifically Developed for the Preventive Treatment of Migraine Biotech Investing
Gilead Marks Fifth Approval for Trodelvy® in Metastatic Triple-Negative Breast Cancer Under Project Orbis Initiative with Health Canada Authorization Biotech Investing
Americans are Frustrated by Unexpected Blurry Near Vision Issues, a New Survey Reveals Biotech Investing
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's Applications for Opdivo + Yervoy and Opdivo + Chemotherapy for Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Biotech Investing
FDA Approves Repatha® In Pediatric Patients Age 10 And Older With Heterozygous Familial Hypercholesterolemia Biotech Investing
AbbVie Presents New Data Analyses for Growing Dermatology Portfolio at the 30th European Academy of Dermatology and Venereology Congress Biotech Investing
BriaCell Therapeutics CEO Emphasizes Recent Key Developments in Audio Interview with SmallCapVoice.com Biotech Investing
BELLUS Health Announces Completion of Patient Enrollment in SOOTHE Phase 2b Trial for Refractory Chronic Cough and BLUEPRINT Phase 2a Trial for Chronic Pruritus Associated with Atopic Dermatitis Biotech Investing
